Discover how Catalent's Rapid Antibody platform delivers GMP drug substance in 8 months, accelerating mAb development from gene construct to IND readiness.

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has issued a Material Qualification Certificate for ELAREM™ ...

Kincell Bio, a leading U.S. cell therapy contract development and manufacturing organization (CDMO), today announced a new collaboration with RegCell, a biotechnology company developing first‑in‑class ...

Invests £400 million to expand biomanufacturing and process development in the North East of England.

Designed specifically for bioreactor-scale workflows, the Krakatoa (R) K500 requires less than 15 minutes of hands-on time and produces up to 500 liters in less than three hours. Two standard pod ...

Fractal Analytics' IPO was 2.66 times oversubscribed, but grey market trends suggest shares may list below the offer price. The company serves major clients like Microsoft and Apple, reflecting strong ...

Nucleus Biologics launched the Krakatoa® K500, a pod-based, on-demand manufacturing system that produces 35–500L of media and ...

[헤럴드경제=손미정 기자] 청각장애인도 차별 없이 재난방송을 시청할 수 있게 된다. 방송미디어통신위원회(위원장 김종철)는 10일 청각장애인의 재난방송 접근권을 강화하기 위해 한국수어를 통해 재난방송 등을 실시하도록 하는 ...

SHENZHEN, GUANGDONG, CHINA, January 22, 2026 /EINPresswire.com/ -- As the global beauty and haircare market continues ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety ...

Gyala Therapeutics initiates phase I/IIa trial of a CAR-T cell therapy for acute leukaemias with limited treatment: Barcelona, Spain Wednesday, February 11, 2026, 18:00 Hrs [IST] ...